Newsbenzinga
TD Cowen Maintains Buy on LENZ Therapeutics, Lowers Price Target to $50
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Please check the source for details.
An excerpt from the original article.Preparing English content…
Comments —
Loading comments…